Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells

Estradiol (E2) increases not only the cell growth but also the Cancer stem cell (CSC) proportion in Estrogen Receptor (ER)-positive breast Cancer cells. It has been suggested that the non-canonical Hedgehog (Hh) pathway activated by E2 plays an important role in the regulation of CSC proportion in ER-positive breast Cancer cells. We studied anti-CSC activity of a non-canonical Hh inhibitor GANT61 in ER-positive breast Cancer cells. Effects of GANT61 on the cell growth, cell cycle progression, Apoptosis and CSC proportion were investigated in four ER-positive breast Cancer cell lines. CSC proportion was measured using either the mammosphere assay or CD44/CD24 assay. Expression levels of pivotal molecules in the Hh pathway were measured. Combined effects of GANT61 with antiestrogens on the anti-cell growth and anti-CSC activities were investigated. E2 significantly increased the cell growth and CSC proportion in all ER-positive cell lines. E2 increased the expression levels of glioma-associated oncogene (Gli) 1 and/or GLI2. GANT61 decreased the cell growth in association with a G1-S cell cycle retardation and increased Apoptosis. GANT61 decreased the E2-induced CSC proportion measured by the mammosphere assay in all cell lines. Antiestrogens also decreased the E2-induced cell growth and CSC proportion. Combined treatments of GANT61 with antiestrogens additively enhanced anti-cell growth and/or anti-CSC activities in some ER-positive cell lines. In conclusion, the non-canonical Hh inhibitor GANT61 inhibited not only the cell growth but also the CSC proportion increased by E2 in ER-positive breast Cancer cells. GANT61 enhanced anti-cell growth and/or anti-CSC activities of antiestrogens in ER-positive cell lines.